These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7955054)

  • 21. Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats.
    Denda A; Tang Q; Endoh T; Tsujiuchi T; Horiguchi K; Noguchi O; Mizumoto Y; Nakae D; Konishi Y
    Carcinogenesis; 1994 Jun; 15(6):1279-83. PubMed ID: 8020168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid of exogenous and endogenous development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in the livers of rats.
    Tamura K; Nakae D; Horiguchi K; Akai H; Kobayashi Y; Andoh N; Satoh H; Denda A; Tsujiuchi T; Yoshiji H; Konishi Y
    Carcinogenesis; 1997 Nov; 18(11):2133-41. PubMed ID: 9395213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats.
    Hayashizaki-Someya Y; Kurosaki E; Takasu T; Mitori H; Yamazaki S; Koide K; Takakura S
    Eur J Pharmacol; 2015 May; 754():19-24. PubMed ID: 25701721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of N,N'-diphenyl-p-phenylenediamine on the early stage of the enhanced hepatocarcinogenesis caused by coadministration of ethionine and a choline-deficient L-amino acid-defined diet in rats.
    Kobayashi E; Tsujiuchi T; Nakae D; Mizumoto Y; Andoh N; Endoh T; Kitada H; Tsutsumi M; Denda A; Konishi Y
    Exp Toxicol Pathol; 1996 Jun; 48(4):275-82. PubMed ID: 8811295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats.
    Nakae D; Yoshiji H; Mizumoto Y; Horiguchi K; Shiraiwa K; Tamura K; Denda A; Konishi Y
    Cancer Res; 1992 Sep; 52(18):5042-5. PubMed ID: 1516060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative changes in the liver of female Fischer-344 rats after short-term feeding of a semipurified or a semisynthetic L-amino acid-defined choline-deficient diet.
    Nakae D; Mizumoto Y; Andoh N; Tamura K; Horiguchi K; Endoh T; Kobayashi E; Tsujiuchi T; Denda A; Lombardi B
    Toxicol Pathol; 1995; 23(5):583-90. PubMed ID: 8578101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-defined diet-induced rat liver fibrosis.
    Hironaka K; Sakaida I; Uchida K; Okita K
    Dig Dis Sci; 2000 Oct; 45(10):1935-43. PubMed ID: 11117563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
    Yamamoto H; Kondo M; Nakamori S; Nagano H; Wakasa K; Sugita Y; Chang-De J; Kobayashi S; Damdinsuren B; Dono K; Umeshita K; Sekimoto M; Sakon M; Matsuura N; Monden M
    Gastroenterology; 2003 Aug; 125(2):556-71. PubMed ID: 12891558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition by phenyl N-tert-butyl nitrone of early phase carcinogenesis in the livers of rats fed a choline-deficient, L-amino acid-defined diet.
    Nakae D; Kotake Y; Kishida H; Hensley KL; Denda A; Kobayashi Y; Kitayama W; Tsujiuchi T; Sang H; Stewart CA; Tabatabaie T; Floyd RA; Konishi Y
    Cancer Res; 1998 Oct; 58(20):4548-51. PubMed ID: 9788598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Jin H; Sakaida I; Tsuchiya M; Okita K
    Life Sci; 2005 Apr; 76(24):2805-16. PubMed ID: 15808881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of inhibitors of prolyl 4-hydroxylase in CCl4-induced fibrosis of the liver in rats.
    Bickel M; Baader E; Brocks DG; Engelbart K; Günzler V; Schmidts HL; Vogel GH
    J Hepatol; 1991; 13 Suppl 3():S26-33; discussion S34. PubMed ID: 1667666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic rat liver.
    Fujiwara K; Ogata I; Ohta Y; Hayashi S; Mishiro S; Takatsuki K; Sato Y; Yamada S; Hirata K; Oka H
    Hepatology; 1988; 8(4):804-7. PubMed ID: 2839404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.
    Rao A; van de Peppel IP; Gumber S; Karpen SJ; Dawson PA
    Front Med (Lausanne); 2020; 7():60. PubMed ID: 32158763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrosis of the liver in rats induced by bile duct ligation. Effects of inhibition by prolyl 4-hydroxylase.
    Böker K; Schwarting G; Kaule G; Günzler V; Schmidt E
    J Hepatol; 1991; 13 Suppl 3():S35-40. PubMed ID: 1667667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent fibrosis in the liver of choline-deficient and iron-supplemented L-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation.
    Takeuchi-Yorimoto A; Noto T; Yamada A; Miyamae Y; Oishi Y; Matsumoto M
    Toxicol Appl Pharmacol; 2013 May; 268(3):264-77. PubMed ID: 23481610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of proton NMR spectroscopy in the study of lipid metabolites in a rat hepatocarcinogenesis model.
    Tesiram YA; Saunders D; Towner RA
    Biochim Biophys Acta; 2005 Oct; 1737(1):61-8. PubMed ID: 16230047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma development.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Yamazaki M; Tsujinoue H; Imazu H; Fukui H
    Oncol Rep; 2003; 10(4):957-62. PubMed ID: 12792752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet.
    Denda A; Kitayama W; Kishida H; Murata N; Tsutsumi M; Tsujiuchi T; Nakae D; Konishi Y
    Jpn J Cancer Res; 2002 Feb; 93(2):125-32. PubMed ID: 11856475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the development of hepatocellular carcinomas by phenyl N-tert-butyl nitrone in rats fed with a choline-deficient, L-amino acid-defined diet.
    Nakae D; Uematsu F; Kishida H; Kusuoka O; Katsuda S; Yoshida M; Takahashi M; Maekawa A; Denda A; Konishi Y; Kotake Y; Floyd RA
    Cancer Lett; 2004 Mar; 206(1):1-13. PubMed ID: 15019154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.